🦊/Lists

Biotech Investors & VC Firms in United States

1265 firms in this list, with a median first check of $500K. 278 of them lead rounds. Generated from verified public data and updated continuously.

EcoR1 Capital
San FranciscoSeed–Late Stage
17 people
Innosphere Ventures
Fort CollinsPre-Seed–Series B
38 people
Section 32
Palo AltoPre-Seed–Series A
23 people
venBio Partners
San FranciscoSeed–Late Stage
11 people
Samsara BioCapital
Palo AltoSeed–Late Stage
7 people
Digitalis Ventures
New YorkSeed–Late Stage$100K – $10M
15 people
Boulder Ventures
BoulderSeries A$1M – $4M
8 people
Modi Ventures
HoustonSeed–Series A
22 people
Broadview Ventures
BostonSeed–Late Stage
20 people
SPRINGROCK VENTURES
SeattleSeed–Late Stage$2M – $5M
16 people
T. Rowe Price
BaltimoreSeed–Late Stage
2 people
Argonautic Ventures
New YorkPre-Seed–Growth$5M
9 people
Dreamers VC
El SegundoSeed–Series B$500K – $5M
9 people
AIX Ventures
San FranciscoPre-Seed–Series A$1M – $5M
8 people
BioAdvance
ConshohockenPre-Seed–Late Stage$500K – $1.5M
16 people
HAWKTAIL
San FranciscoPre-Seed–Seed
3 people
Excelerate Health Ventures
Research Triangle ParkSeed–Series A
31 people
First Analysis
ChicagoSeries A–Late Stage
24 people
Emles Venture Partners
New YorkPre-Seed–Seed
14 people
SeaX Ventures
MillbraePre-Seed–Series A$100K – $5M
32 people
WI Harper Group
San FranciscoSeed–Series C$5M – $15M
24 people
UpHonest Capital
Silicon ValleyPre-Seed–Series B$50K – $1M
17 people
Next Level Ventures
Des MoinesSeed–Late Stage$500K – $5M
15 people
CEI Ventures
BrunswickSeed–Late Stage$1M – $4M
16 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.